Business
Thai solar power producer Sermsang to sell 30% stake in IPO
Currently, Sermsang Power has operated a solar energy farm with the installed capacity of 52 megawatts in Lopburi province
Sermsang Power Corporation, Thai alternative energy producer, plans to sell 276.38 million shares, equivalent to 30 per cent of the total registered capital, in an initial public offering (IPO) in Thailand.
It submitted the first filing to the Office of Securities and Exchange Commission on January 31 and is to be listed on the Market for Alternative Investment.
Of the total IPO shares, the newly issued shares will not exceed 230.375 million shares and the existing shareholders sell out will not exceed 46 million shares, the filing said.
In the filing, the company said that the IPO proceeds will be used to expand the business domestically and internationally and repay the loan over the next three years.
Currently, Sermsang Power has operated a solar energy farm with the installed capacity of 52 megawatts in Lopburi province and made a joint venture in a solar farm with the installed capacity of 21 megawatts in Japan under the GK-TK scheme.
The project in Japan, with total investment of 7.82-8.32 billion yen, remains under the construction. It is scheduled to commence a commercial operation in the first quarter of next year.
According to the filing, it has a registered capital of 922 million baht, divided into 922 million shares at the par value of 1 baht. It reported the revenue of 660 million baht and the net profit of 385.6 million baht for the first nine months of last year.
Primary Energy Co Ltd, the major shareholder, makes up for 40 per cent, followed by Unity I. Capital Limited holding 35 per cent and Mr. Wiwat Kraipisitkul sharing 10 per cent.
After IPO, Primary Energy’s shares will be diluted to 30 per cent, Unity I. Capital Limited 21.3 per cent and Kraipisitkul 7.5 per cent.
It appoints Kasikorn Securities as a financial advisor and lead underwriter for the IPO.
DEALSTREETASIA Pte. Ltd. is a news and intelligence platform providing reports on investments, mergers, acquisitions, private equity, venture capital, investment banking and the business of startups across the Asian region.
Business
Large Shopping Malls in Bangkok Will Be Closed until July 25th
Shopping malls under the Mall Group, including all branches of The Mall, the Emporium, Emquartier and Paragon Department Store, are also closed for 14 days, from today, except for supermarkets, food courts, pharmacy shops, eateries (take-out and delivery only), banks, mobile phone shops and vaccination sites.
BANGKOK (NNT) – Large-scale shopping malls in Bangkok and in some dark-red zone provinces are now closed for two weeks, to comply with the latest COVID-19 curbs in 10 provinces.
(more…)
Business
Downside risks loom for Thai economy due to Prolonged COVID-19 Outbreak
The most important issue for the Thai economy at present would be the procurement and distribution of appropriate vaccines adequately and timely.
The Bank of Thailand (BoT) has revealed that Thailand’s economy faces significant downside risks, because a prolonged COVID-19 outbreak could cause the economy to underperform the baseline projection, squeezing business liquidity and slowing employment.
(more…)
Asia’s slow rate of vaccination is a thorn in the region’s economic recovery
Southeast Asia has been hit badly. Daily infections for Indonesia, Thailand, Vietnam are at their worst, on a seven-day moving...
TAT expects 850 billion baht ($25.7 bln) in tourism revenue after successful reopening
The Tourism Authority of Thailand (TAT) has set this year’s revenue target at 850 billion baht, 300 billion of which...
Download 1xBet mobile and play all over the world
Placing profitable bets or playing in a casino is now possible comfortably even without being tied to a computer. It...
3 ways Asia can recover from the COVID-19 pandemic faster
Countries in the East Asia and Pacific region will benefit from cooperation in three major areas: vaccine deployment, reviving sectors...
Thailand’s Vaccine Strategy: What went wrong?
Questions are being asked, and not answered, over the decision to rely almost entirely on Siam Bioscience, a local, palace-owned...